About the study interpretation category
|
|
0
|
3658
|
July 21, 2018
|
Immortal-time-bias vs. selection bias
|
|
2
|
683
|
April 7, 2024
|
Problems with NNT
|
|
36
|
36407
|
February 19, 2024
|
Language for communicating frequentist results about treatment effects
|
|
200
|
116259
|
January 9, 2024
|
Article: JAMA meta-analysis of Placebo response and cannabis based therapies for pain
|
|
2
|
1128
|
December 3, 2022
|
Language regarding confidence in "negative" results
|
|
0
|
791
|
October 5, 2022
|
Should adverse effects be adjusted for multiple comparisons?
|
|
4
|
3247
|
May 24, 2022
|
Understanding "BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination Setting]"
|
|
0
|
1899
|
January 18, 2022
|
Delphi Method Consensus
|
|
0
|
2236
|
December 9, 2021
|
Interpretation of the REGEN-COV trial
|
|
22
|
10758
|
November 1, 2021
|
Mathematical behavior of the primary endpoint
|
|
13
|
9759
|
March 2, 2021
|
Making sense of significant interaction with null main effect in RCT
|
|
3
|
10890
|
December 24, 2020
|
What are credible priors and what are skeptical priors?
|
|
62
|
32074
|
June 9, 2020
|
Lower limit of the confidence interval for measuring the magnitude of clinical benefit
|
|
8
|
4488
|
April 17, 2020
|
Very small effect size wih significant p-value
|
|
9
|
8692
|
April 5, 2020
|
What to interpret when observed effect size is smaller but statistically significant than expected effect size
|
|
18
|
17436
|
January 29, 2020
|
Prophetic variable in survival analysis - or not?
|
|
3
|
5052
|
January 3, 2020
|
Drawing inferences from frequentist point estimates with wide confidence intervals
|
|
2
|
3237
|
December 10, 2019
|
Comparing Beta coefficients
|
|
4
|
6159
|
October 11, 2019
|
Fragility Index
|
|
31
|
13510
|
August 24, 2019
|
Updates to NEJM Statistical Guidelines for Authors
|
|
20
|
16656
|
August 11, 2019
|
Interpreting the results of two non-inferiority trials
|
|
14
|
9555
|
July 31, 2019
|
GRADE guidelines and effect estimate & CIs
|
|
19
|
11716
|
July 10, 2019
|
Uncovering Waste in U.S. Healthcare
|
|
0
|
4058
|
June 14, 2019
|
CREOLE Trial: Interpretation of results doesn't line up with statistical plan?
|
|
7
|
5184
|
March 30, 2019
|
Most reasonably hypothesised effects cannot be exactly zero?
|
|
13
|
9256
|
March 29, 2019
|
Treatment effect heterogeneity: or is it?
|
|
12
|
8200
|
March 28, 2019
|
What does it mean when a test/predictor is 'predictive on the aggregate level but not on the individual level'
|
|
3
|
4020
|
March 6, 2019
|
Statistical methods for establishing the "insufficiency" of data cutoffs
|
|
0
|
3048
|
March 1, 2019
|
Proofs of Nulls: P > 0.05
|
|
24
|
17802
|
February 22, 2019
|